Allosteric Hsp70 Modulator YM-1 Induces Degradation of BRD4

Yugo Mishima1, Shusuke Tomoshige1, Shinichi Sato1,2

  • 1Graduate School of Life Sciences, Tohoku University.

PubMed

Insights

YM-1, a heat-shock 70 kDa protein (Hsp70) modulator, triggers cancer cell death by promoting the degradation of bromodomain containing 4 (BRD4). This mechanism involves Hsp70, CHIP, and BRD4 ubiquitination, leading to reduced oncogene expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Heat-shock 70 kDa protein (Hsp70) is a crucial molecular chaperone implicated in cancer.
  • YM-1 is an allosteric modulator of Hsp70 with known anticancer properties, but its precise mechanism of action remains unclear.
  • Bromodomain containing 4 (BRD4) is a key regulator of oncogene expression and a validated therapeutic target in various cancers.

Purpose of the Study:

  • To elucidate the molecular mechanism by which YM-1 inhibits cancer cell growth.
  • To investigate the role of Hsp70 and its interacting partners in YM-1-mediated anti-cancer effects.
  • To determine if YM-1 affects the stability or expression of BRD4.

Main Methods:

  • Cell-based assays to assess cancer cell viability and proliferation.
  • Western blotting and immunoprecipitation to detect protein-protein interactions and degradation.
  • Ubiquitination assays to identify the role of E3 ligases.
  • Quantitative real-time PCR to measure gene expression levels.

Main Results:

  • YM-1 treatment led to the degradation of BRD4 in cancer cells.
  • YM-1 enhanced the binding between Hsp70 and BRD4.
  • Hsp70-mediated recruitment of C-terminus of Hsc70-interacting protein (CHIP) resulted in BRD4 ubiquitination and subsequent proteasomal degradation.
  • The decrease in BRD4 levels correlated with reduced oncogene expression and inhibited cancer cell growth.

Conclusions:

  • YM-1 inhibits cancer cell growth by inducing the proteasomal degradation of BRD4.
  • The mechanism involves the formation of an Hsp70-BRD4 complex, facilitating BRD4 ubiquitination by CHIP.
  • Targeting the Hsp70-BRD4-CHIP axis represents a potential therapeutic strategy for cancers driven by BRD4.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.0K